Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
| UnnamedSample_HQ_transcript/8652|m.3393 | UnnamedSample_HQ_transcript/8652 | Identity 0.857 too low. | 140c9c5e0efb8c4ed14ffc77d9db63f0 | 1302 | Pfam | PF00063 | Myosin head (motor domain) | 1 | 106 | 6.4E-38 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/8652|m.3393 | UnnamedSample_HQ_transcript/8652 | Identity 0.857 too low. | 140c9c5e0efb8c4ed14ffc77d9db63f0 | 1302 | Pfam | PF01576 | Myosin tail | 186 | 1263 | 1.9E-164 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/98424|m.22423 | UnnamedSample_HQ_transcript/98424 | Coverage 0.878 too low. | f650edecdfacc3a7884fbfa6cd3721e1 | 161 | Pfam | PF00307 | Calponin homology (CH) domain | 81 | 159 | 7.9E-15 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/10435|m.3966 | UnnamedSample_HQ_transcript/10435 | Coverage 0.660 too low. | 75147cae515b3a99925144f5084bd1c9 | 1027 | Pfam | PF00621 | RhoGEF domain | 586 | 767 | 7.4E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/10435|m.3966 | UnnamedSample_HQ_transcript/10435 | Coverage 0.660 too low. | 75147cae515b3a99925144f5084bd1c9 | 1027 | Pfam | PF12738 | twin BRCT domain | 197 | 237 | 1.0E-4 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/10435|m.3966 | UnnamedSample_HQ_transcript/10435 | Coverage 0.660 too low. | 75147cae515b3a99925144f5084bd1c9 | 1027 | Pfam | PF12738 | twin BRCT domain | 102 | 164 | 5.6E-17 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/42055|m.12275 | UnnamedSample_HQ_transcript/42055 | Coverage 0.095 too low. | 3cd01ffa449efd226fa2a65bcd091d0f | 500 | Pfam | PF00581 | Rhodanese-like domain | 342 | 448 | 1.5E-14 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/20924|m.7129 | UnnamedSample_HQ_transcript/20924 | Coverage 0.988 too low. | 34ba85e7a6690b509199e9556a0c36c1 | 853 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 551 | 853 | 8.4E-93 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/119339|m.24802 | UnnamedSample_HQ_transcript/119339 | Identity 0.939 too low. | c06c0269dd22999fc3439a5b40fe105f | 108 | Pfam | PF13639 | Ring finger domain | 52 | 94 | 6.3E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/118345|m.24710 | UnnamedSample_HQ_transcript/118345 | Identity 0.942 too low. | c06c0269dd22999fc3439a5b40fe105f | 108 | Pfam | PF13639 | Ring finger domain | 52 | 94 | 6.3E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/101800|m.22843 | UnnamedSample_HQ_transcript/101800 | Coverage 0.901 too low. | 3698fd343045e3859a12a98d58d8b0a8 | 169 | Pfam | PF07002 | Copine | 2 | 163 | 1.9E-62 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/21570|m.7301 | UnnamedSample_HQ_transcript/21570 | Identity 0.775 too low. | 1cd17273f8f7764429e24278176eeae2 | 679 | Pfam | PF04987 | Phosphatidylinositolglycan class N (PIG-N) | 164 | 621 | 4.4E-96 | T | 22-09-2020 | IPR017852 | GPI ethanolamine phosphate transferase 1, C-terminal |
| UnnamedSample_HQ_transcript/55818|m.15195 | UnnamedSample_HQ_transcript/55818 | Coverage 0.899 too low. | 239cc19e60012eaa3d2f31070e53014f | 445 | Pfam | PF00787 | PX domain | 97 | 180 | 4.6E-20 | T | 22-09-2020 | IPR001683 | Phox homologous domain |
| UnnamedSample_HQ_transcript/55818|m.15195 | UnnamedSample_HQ_transcript/55818 | Coverage 0.899 too low. | 239cc19e60012eaa3d2f31070e53014f | 445 | Pfam | PF09325 | Vps5 C terminal like | 214 | 434 | 1.3E-9 | T | 22-09-2020 | IPR015404 | Sorting nexin Vps5-like, C-terminal |
| UnnamedSample_HQ_transcript/59597|m.15975 | UnnamedSample_HQ_transcript/59597 | Coverage 0.883 too low. | 239cc19e60012eaa3d2f31070e53014f | 445 | Pfam | PF00787 | PX domain | 97 | 180 | 4.6E-20 | T | 22-09-2020 | IPR001683 | Phox homologous domain |
| UnnamedSample_HQ_transcript/59597|m.15975 | UnnamedSample_HQ_transcript/59597 | Coverage 0.883 too low. | 239cc19e60012eaa3d2f31070e53014f | 445 | Pfam | PF09325 | Vps5 C terminal like | 214 | 434 | 1.3E-9 | T | 22-09-2020 | IPR015404 | Sorting nexin Vps5-like, C-terminal |
| UnnamedSample_HQ_transcript/82906|m.20179 | UnnamedSample_HQ_transcript/82906 | Coverage 0.979 too low. | 805c2714daa24066ac16f25a34adaee4 | 288 | Pfam | PF02661 | Fic/DOC family | 115 | 212 | 5.2E-12 | T | 22-09-2020 | IPR003812 | Fido domain |
| UnnamedSample_HQ_transcript/66959|m.17404 | UnnamedSample_HQ_transcript/66959 | Coverage 0.981 too low. | 805c2714daa24066ac16f25a34adaee4 | 288 | Pfam | PF02661 | Fic/DOC family | 115 | 212 | 5.2E-12 | T | 22-09-2020 | IPR003812 | Fido domain |
| UnnamedSample_HQ_transcript/76330|m.19084 | UnnamedSample_HQ_transcript/76330 | Coverage 0.979 too low. | 805c2714daa24066ac16f25a34adaee4 | 288 | Pfam | PF02661 | Fic/DOC family | 115 | 212 | 5.2E-12 | T | 22-09-2020 | IPR003812 | Fido domain |
| UnnamedSample_HQ_transcript/42492|m.12371 | UnnamedSample_HQ_transcript/42492 | Coverage 0.578 too low. | e0f01a7b430e0fb18f67e6c11cfa3186 | 681 | Pfam | PF07993 | Male sterility protein | 35 | 269 | 3.7E-53 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/42492|m.12371 | UnnamedSample_HQ_transcript/42492 | Coverage 0.578 too low. | e0f01a7b430e0fb18f67e6c11cfa3186 | 681 | Pfam | PF00106 | short chain dehydrogenase | 415 | 604 | 4.2E-50 | T | 22-09-2020 | IPR002347 | Short-chain dehydrogenase/reductase SDR |
| UnnamedSample_HQ_transcript/89455|m.21155 | UnnamedSample_HQ_transcript/89455 | Identity 0.920 too low. | 2c030183e3ac70d32732dede1ac9b5f4 | 346 | Pfam | PF09820 | Predicted AAA-ATPase | 49 | 332 | 1.8E-45 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/88876|m.21067 | UnnamedSample_HQ_transcript/88876 | Coverage 0.708 too low. | c2168b87e42f68cab083588ac5ed82af | 253 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 60 | 223 | 6.4E-64 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/78678|m.19496 | UnnamedSample_HQ_transcript/78678 | Coverage 0.752 too low. | c2168b87e42f68cab083588ac5ed82af | 253 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 60 | 223 | 6.4E-64 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/72901|m.18458 | UnnamedSample_HQ_transcript/72901 | Coverage 0.768 too low. | c2168b87e42f68cab083588ac5ed82af | 253 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 60 | 223 | 6.4E-64 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/68880|m.17740 | UnnamedSample_HQ_transcript/68880 | Identity 0.931 too low. | cd37a3e99ded9ba2f3b1c7bc1c06a085 | 451 | Pfam | PF01044 | Vinculin family | 2 | 449 | 8.8E-167 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/48845|m.13767 | UnnamedSample_HQ_transcript/48845 | Identity 0.856 too low. | cd37a3e99ded9ba2f3b1c7bc1c06a085 | 451 | Pfam | PF01044 | Vinculin family | 2 | 449 | 8.8E-167 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/100371|m.22693 | UnnamedSample_HQ_transcript/100371 | Coverage 0.141 too low. | 9360e0fd098cde639a0fff88b3ad6530 | 167 | Pfam | PF01302 | CAP-Gly domain | 6 | 70 | 1.3E-24 | T | 22-09-2020 | IPR000938 | CAP Gly-rich domain |
| UnnamedSample_HQ_transcript/37409|m.11251 | UnnamedSample_HQ_transcript/37409 | Identity 0.742 too low. | c893a74787ae88251d6c361394b04d6d | 705 | Pfam | PF17047 | Synaptotagmin-like mitochondrial-lipid-binding domain | 4 | 168 | 4.6E-34 | T | 22-09-2020 | IPR039010 | Synaptotagmin, SMP domain |
| UnnamedSample_HQ_transcript/37409|m.11251 | UnnamedSample_HQ_transcript/37409 | Identity 0.742 too low. | c893a74787ae88251d6c361394b04d6d | 705 | Pfam | PF00168 | C2 domain | 593 | 698 | 1.4E-15 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/37409|m.11251 | UnnamedSample_HQ_transcript/37409 | Identity 0.742 too low. | c893a74787ae88251d6c361394b04d6d | 705 | Pfam | PF00168 | C2 domain | 185 | 291 | 4.5E-19 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/37409|m.11251 | UnnamedSample_HQ_transcript/37409 | Identity 0.742 too low. | c893a74787ae88251d6c361394b04d6d | 705 | Pfam | PF00168 | C2 domain | 335 | 426 | 1.8E-8 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/56724|m.15385 | UnnamedSample_HQ_transcript/56724 | Identity 0.902 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 389 | 424 | 6.9E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/56724|m.15385 | UnnamedSample_HQ_transcript/56724 | Identity 0.902 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 224 | 253 | 0.23 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/48136|m.13614 | UnnamedSample_HQ_transcript/48136 | Coverage 0.947 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 389 | 424 | 6.9E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/48136|m.13614 | UnnamedSample_HQ_transcript/48136 | Coverage 0.947 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 224 | 253 | 0.23 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/55094|m.15058 | UnnamedSample_HQ_transcript/55094 | Coverage 0.959 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 389 | 424 | 6.9E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/55094|m.15058 | UnnamedSample_HQ_transcript/55094 | Coverage 0.959 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 224 | 253 | 0.23 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/57452|m.15535 | UnnamedSample_HQ_transcript/57452 | Coverage 0.942 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 389 | 424 | 6.9E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/57452|m.15535 | UnnamedSample_HQ_transcript/57452 | Coverage 0.942 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 224 | 253 | 0.23 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/61721|m.16394 | UnnamedSample_HQ_transcript/61721 | Coverage 0.941 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 389 | 424 | 6.9E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/61721|m.16394 | UnnamedSample_HQ_transcript/61721 | Coverage 0.941 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 224 | 253 | 0.23 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/71058|m.18120 | UnnamedSample_HQ_transcript/71058 | Coverage 0.960 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 389 | 424 | 6.9E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/71058|m.18120 | UnnamedSample_HQ_transcript/71058 | Coverage 0.960 too low. | fb40f98f09b824052537368441d86106 | 465 | Pfam | PF00400 | WD domain, G-beta repeat | 224 | 253 | 0.23 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/34693|m.10649 | UnnamedSample_HQ_transcript/34693 | Coverage 0.735 too low. | ffb21858978fc8603739c81895bdf33d | 487 | Pfam | PF00041 | Fibronectin type III domain | 337 | 410 | 1.4E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/34693|m.10649 | UnnamedSample_HQ_transcript/34693 | Coverage 0.735 too low. | ffb21858978fc8603739c81895bdf33d | 487 | Pfam | PF07679 | Immunoglobulin I-set domain | 236 | 321 | 5.7E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/34693|m.10649 | UnnamedSample_HQ_transcript/34693 | Coverage 0.735 too low. | ffb21858978fc8603739c81895bdf33d | 487 | Pfam | PF07679 | Immunoglobulin I-set domain | 121 | 205 | 6.6E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/34693|m.10649 | UnnamedSample_HQ_transcript/34693 | Coverage 0.735 too low. | ffb21858978fc8603739c81895bdf33d | 487 | Pfam | PF07679 | Immunoglobulin I-set domain | 46 | 100 | 8.4E-7 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/47661|m.13503 | UnnamedSample_HQ_transcript/47661 | Coverage 0.626 too low. | 57988539678486233f63d6ccfe3e4bfb | 546 | Pfam | PF00168 | C2 domain | 395 | 506 | 3.8E-8 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/2759|m.1346 | UnnamedSample_HQ_transcript/2759 | Coverage 0.757 too low. | 81fb74a5209e519aec3d6f89b2a37d49 | 1714 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 239 | 349 | 1.1E-20 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/2759|m.1346 | UnnamedSample_HQ_transcript/2759 | Coverage 0.757 too low. | 81fb74a5209e519aec3d6f89b2a37d49 | 1714 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 45 | 136 | 3.1E-19 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/2759|m.1346 | UnnamedSample_HQ_transcript/2759 | Coverage 0.757 too low. | 81fb74a5209e519aec3d6f89b2a37d49 | 1714 | Pfam | PF01843 | DIL domain | 813 | 915 | 2.9E-30 | T | 22-09-2020 | IPR002710 | Dilute domain |
| UnnamedSample_HQ_transcript/2759|m.1346 | UnnamedSample_HQ_transcript/2759 | Coverage 0.757 too low. | 81fb74a5209e519aec3d6f89b2a37d49 | 1714 | Pfam | PF00595 | PDZ domain | 1043 | 1123 | 8.9E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2759|m.1346 | UnnamedSample_HQ_transcript/2759 | Coverage 0.757 too low. | 81fb74a5209e519aec3d6f89b2a37d49 | 1714 | Pfam | PF00498 | FHA domain | 428 | 485 | 3.6E-6 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/99305|m.22541 | UnnamedSample_HQ_transcript/99305 | Coverage 0.896 too low. | 170c5d90b46e08a079994059c62ebbc9 | 346 | Pfam | PF00319 | SRF-type transcription factor (DNA-binding and dimerisation domain) | 43 | 89 | 1.4E-19 | T | 22-09-2020 | IPR002100 | Transcription factor, MADS-box |
| UnnamedSample_HQ_transcript/30408|m.9568 | UnnamedSample_HQ_transcript/30408 | Coverage 0.973 too low. | ed34fced35450a04fa57c3b9744ef77d | 855 | Pfam | PF00096 | Zinc finger, C2H2 type | 6 | 26 | 0.0014 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/30408|m.9568 | UnnamedSample_HQ_transcript/30408 | Coverage 0.973 too low. | ed34fced35450a04fa57c3b9744ef77d | 855 | Pfam | PF10551 | MULE transposase domain | 398 | 492 | 1.1E-11 | T | 22-09-2020 | IPR018289 | MULE transposase domain |
| UnnamedSample_HQ_transcript/165|m.154 | UnnamedSample_HQ_transcript/165 | Unmapped. | 7fc1325a00f8256951b3d773c1e02cd5 | 2630 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 2359 | 2624 | 6.3E-31 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/165|m.154 | UnnamedSample_HQ_transcript/165 | Unmapped. | 7fc1325a00f8256951b3d773c1e02cd5 | 2630 | Pfam | PF00910 | RNA helicase | 1297 | 1405 | 1.0E-17 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/165|m.154 | UnnamedSample_HQ_transcript/165 | Unmapped. | 7fc1325a00f8256951b3d773c1e02cd5 | 2630 | Pfam | PF08762 | CRPV capsid protein like | 673 | 883 | 7.0E-11 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/82446|m.20101 | UnnamedSample_HQ_transcript/82446 | Identity 0.941 too low. | e2959bef866a814c285f081d7db262d9 | 250 | Pfam | PF04685 | Glycosyl-hydrolase family 116, catalytic region | 1 | 240 | 2.5E-105 | T | 22-09-2020 | IPR006775 | Glycosyl-hydrolase family 116, catalytic region |
| UnnamedSample_HQ_transcript/32728|m.10143 | UnnamedSample_HQ_transcript/32728 | Identity 0.802 too low. | 3605848d66d2c10aadeac2c03ea54324 | 467 | Pfam | PF01576 | Myosin tail | 2 | 465 | 2.5E-69 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/41512|m.12161 | UnnamedSample_HQ_transcript/41512 | Identity 0.573 too low. | a12672a8ea609a92c44418612b16611f | 107 | Pfam | PF17862 | AAA+ lid domain | 10 | 46 | 4.7E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/1253|m.747 | UnnamedSample_HQ_transcript/1253 | Coverage 0.323 too low. | 2deb51a1471063baaf224094b4fc7510 | 596 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 377 | 533 | 1.9E-17 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/15475|m.5542 | UnnamedSample_HQ_transcript/15475 | Unmapped. | 40f2878fdd4974977acb49551125bea0 | 1171 | Pfam | PF00910 | RNA helicase | 685 | 793 | 3.9E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/15475|m.5542 | UnnamedSample_HQ_transcript/15475 | Unmapped. | 40f2878fdd4974977acb49551125bea0 | 1171 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 5.6E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/4718|m.2079 | UnnamedSample_HQ_transcript/4718 | Coverage 0.045 too low. | 5a56d8f68ddb3770a3b770d2899b3d7e | 1162 | Pfam | PF19056 | WD40 repeated domain | 822 | 1050 | 9.2E-61 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4718|m.2079 | UnnamedSample_HQ_transcript/4718 | Coverage 0.045 too low. | 5a56d8f68ddb3770a3b770d2899b3d7e | 1162 | Pfam | PF00621 | RhoGEF domain | 318 | 498 | 1.0E-35 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/4718|m.2079 | UnnamedSample_HQ_transcript/4718 | Coverage 0.045 too low. | 5a56d8f68ddb3770a3b770d2899b3d7e | 1162 | Pfam | PF19057 | PH domain | 523 | 656 | 3.2E-38 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/78125|m.19395 | UnnamedSample_HQ_transcript/78125 | Coverage 0.978 too low. | 5ae07216a61a2f9aba0d3f2dfca3ba50 | 448 | Pfam | PF03165 | MH1 domain | 28 | 129 | 4.6E-20 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/40917|m.12054 | UnnamedSample_HQ_transcript/40917 | Coverage 0.986 too low. | b55ede8b0ea841866e6b1130d09a52f0 | 662 | Pfam | PF01480 | PWI domain | 1 | 56 | 8.2E-21 | T | 22-09-2020 | IPR002483 | PWI domain |
| UnnamedSample_HQ_transcript/31386|m.9808 | UnnamedSample_HQ_transcript/31386 | Coverage 0.792 too low. | 836aec9c55eac54b76ee022ebef97fcc | 559 | Pfam | PF16179 | Rel homology dimerisation domain | 341 | 432 | 9.5E-25 | T | 22-09-2020 | IPR032397 | Rel homology dimerisation domain |
| UnnamedSample_HQ_transcript/31386|m.9808 | UnnamedSample_HQ_transcript/31386 | Coverage 0.792 too low. | 836aec9c55eac54b76ee022ebef97fcc | 559 | Pfam | PF00554 | Rel homology DNA-binding domain | 174 | 333 | 3.9E-28 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/46389|m.13227 | UnnamedSample_HQ_transcript/46389 | Coverage 0.911 too low. | 094fa701e3c8203068b0d5add1eb977a | 182 | Pfam | PF00487 | Fatty acid desaturase | 12 | 104 | 1.7E-7 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/49393|m.13887 | UnnamedSample_HQ_transcript/49393 | Coverage 0.959 too low. | 094fa701e3c8203068b0d5add1eb977a | 182 | Pfam | PF00487 | Fatty acid desaturase | 12 | 104 | 1.7E-7 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/42411|m.12354 | UnnamedSample_HQ_transcript/42411 | Coverage 0.861 too low. | 094fa701e3c8203068b0d5add1eb977a | 182 | Pfam | PF00487 | Fatty acid desaturase | 12 | 104 | 1.7E-7 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/38884|m.11597 | UnnamedSample_HQ_transcript/38884 | Coverage 0.816 too low. | 094fa701e3c8203068b0d5add1eb977a | 182 | Pfam | PF00487 | Fatty acid desaturase | 12 | 104 | 1.7E-7 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/94620|m.21893 | UnnamedSample_HQ_transcript/94620 | Coverage 0.983 too low. | db1af9710c6dc637e9b6c01c1a23fde1 | 309 | Pfam | PF00248 | Aldo/keto reductase family | 26 | 286 | 4.9E-50 | T | 22-09-2020 | IPR023210 | NADP-dependent oxidoreductase domain |
| UnnamedSample_HQ_transcript/89832|m.21223 | UnnamedSample_HQ_transcript/89832 | Coverage 0.484 too low. | 86c12ff18ecef6e20a4fff9314b37640 | 188 | Pfam | PF08610 | Peroxisomal membrane protein (Pex16) | 13 | 161 | 1.5E-34 | T | 22-09-2020 | IPR013919 | Peroxisome membrane protein, Pex16 |
| UnnamedSample_HQ_transcript/502|m.370 | UnnamedSample_HQ_transcript/502 | Unmapped. | 80342922d24cc017abaf4749deba2b52 | 442 | Pfam | PF13087 | AAA domain | 5 | 77 | 1.4E-10 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/111223|m.23988 | UnnamedSample_HQ_transcript/111223 | Unmapped. | 43467a6fed787277fc2be24bfa82d5f7 | 243 | Pfam | PF00814 | tRNA N6-adenosine threonylcarbamoyltransferase | 24 | 242 | 2.9E-74 | T | 22-09-2020 | IPR000905 | Gcp-like domain |
| UnnamedSample_HQ_transcript/16091|m.5739 | UnnamedSample_HQ_transcript/16091 | Coverage 0.058 too low. | d027bc24a37b2e0df1ead89f317c65e4 | 1001 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 219 | 393 | 4.0E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/16091|m.5739 | UnnamedSample_HQ_transcript/16091 | Coverage 0.058 too low. | d027bc24a37b2e0df1ead89f317c65e4 | 1001 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 49 | 118 | 6.1E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/18209|m.6372 | UnnamedSample_HQ_transcript/18209 | Identity 0.659 too low. | 62215a9bca4d5c040ed5e934a289ffda | 983 | Pfam | PF00005 | ABC transporter | 335 | 478 | 1.7E-27 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/18209|m.6372 | UnnamedSample_HQ_transcript/18209 | Identity 0.659 too low. | 62215a9bca4d5c040ed5e934a289ffda | 983 | Pfam | PF12698 | ABC-2 family transporter protein | 59 | 275 | 1.3E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18209|m.6372 | UnnamedSample_HQ_transcript/18209 | Identity 0.659 too low. | 62215a9bca4d5c040ed5e934a289ffda | 983 | Pfam | PF12698 | ABC-2 family transporter protein | 700 | 982 | 1.7E-22 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/19737|m.6797 | UnnamedSample_HQ_transcript/19737 | Coverage 0.135 too low. | e65f5d11b3a22258d54bce9faec05a6c | 1048 | Pfam | PF00063 | Myosin head (motor domain) | 259 | 394 | 1.6E-32 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/19737|m.6797 | UnnamedSample_HQ_transcript/19737 | Coverage 0.135 too low. | e65f5d11b3a22258d54bce9faec05a6c | 1048 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 806 | 851 | 3.8E-7 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/19737|m.6797 | UnnamedSample_HQ_transcript/19737 | Coverage 0.135 too low. | e65f5d11b3a22258d54bce9faec05a6c | 1048 | Pfam | PF00612 | IQ calmodulin-binding motif | 485 | 502 | 0.012 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/19737|m.6797 | UnnamedSample_HQ_transcript/19737 | Coverage 0.135 too low. | e65f5d11b3a22258d54bce9faec05a6c | 1048 | Pfam | PF00612 | IQ calmodulin-binding motif | 433 | 450 | 0.034 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/19737|m.6797 | UnnamedSample_HQ_transcript/19737 | Coverage 0.135 too low. | e65f5d11b3a22258d54bce9faec05a6c | 1048 | Pfam | PF00612 | IQ calmodulin-binding motif | 460 | 479 | 0.18 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/75457|m.18926 | UnnamedSample_HQ_transcript/75457 | Coverage 0.988 too low. | c20f6b7b5ea6503ee74dcd397129dd1c | 366 | Pfam | PF08652 | RAI1 like PD-(D/E)XK nuclease | 227 | 289 | 1.3E-17 | T | 22-09-2020 | IPR013961 | RAI1-like |
| UnnamedSample_HQ_transcript/45775|m.13094 | UnnamedSample_HQ_transcript/45775 | Coverage 0.713 too low. | 74163daab3ac4b139c6d6a43689fe14e | 519 | Pfam | PF00412 | LIM domain | 149 | 204 | 1.5E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/34468|m.10598 | UnnamedSample_HQ_transcript/34468 | Coverage 0.722 too low. | 1a2aa795a29d32a89469a64fd8b7c759 | 133 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 49 | 109 | 6.3E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/36890|m.11142 | UnnamedSample_HQ_transcript/36890 | Coverage 0.129 too low. | 88a186da9ac70dd283108824edab53a8 | 292 | Pfam | PF10358 | N-terminal C2 in EEIG1 and EHBP1 proteins | 6 | 148 | 7.0E-30 | T | 22-09-2020 | IPR019448 | NT-type C2 domain |
| UnnamedSample_HQ_transcript/17723|m.6229 | UnnamedSample_HQ_transcript/17723 | Coverage 0.776 too low. | aaaa2b2353e7e099622d12a63ff72fea | 804 | Pfam | PF00621 | RhoGEF domain | 363 | 544 | 5.0E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/17723|m.6229 | UnnamedSample_HQ_transcript/17723 | Coverage 0.776 too low. | aaaa2b2353e7e099622d12a63ff72fea | 804 | Pfam | PF12738 | twin BRCT domain | 89 | 151 | 4.1E-17 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/17723|m.6229 | UnnamedSample_HQ_transcript/17723 | Coverage 0.776 too low. | aaaa2b2353e7e099622d12a63ff72fea | 804 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 178 | 249 | 8.9E-6 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/103114|m.23004 | UnnamedSample_HQ_transcript/103114 | Coverage 0.987 too low. | 85a206fccafc6f4905118fb4099f556f | 210 | Pfam | PF00162 | Phosphoglycerate kinase | 9 | 209 | 1.7E-66 | T | 22-09-2020 | IPR001576 | Phosphoglycerate kinase |
| UnnamedSample_HQ_transcript/23705|m.7863 | UnnamedSample_HQ_transcript/23705 | Coverage 0.120 too low. | 266b0d26dc9c25d48217071eb1aea664 | 587 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 291 | 586 | 4.1E-89 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/66675|m.17348 | UnnamedSample_HQ_transcript/66675 | Coverage 0.278 too low. | 7c9818e2f6b07d3bcf47e6c428c55f15 | 168 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 12 | 96 | 2.5E-4 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/59287|m.15905 | UnnamedSample_HQ_transcript/59287 | Coverage 0.848 too low. | 8a6ddaafab6f375aa4c7a5c955fc1cd2 | 336 | Pfam | PF02847 | MA3 domain | 32 | 143 | 4.5E-21 | T | 22-09-2020 | IPR003891 | Initiation factor eIF-4 gamma, MA3 |
| UnnamedSample_HQ_transcript/59287|m.15905 | UnnamedSample_HQ_transcript/59287 | Coverage 0.848 too low. | 8a6ddaafab6f375aa4c7a5c955fc1cd2 | 336 | Pfam | PF02847 | MA3 domain | 197 | 306 | 5.5E-23 | T | 22-09-2020 | IPR003891 | Initiation factor eIF-4 gamma, MA3 |
| UnnamedSample_HQ_transcript/120254|m.24868 | UnnamedSample_HQ_transcript/120254 | Coverage 0.946 too low. | d6d6ff35c4cb2ff75640cf96f9ad6db8 | 138 | Pfam | PF03234 | Cdc37 N terminal kinase binding | 1 | 107 | 1.9E-17 | T | 22-09-2020 | IPR013855 | Cdc37, N-terminal domain |
| UnnamedSample_HQ_transcript/60550|m.16168 | UnnamedSample_HQ_transcript/60550 | Coverage 0.724 too low. | 34fd415d968c9cd16b4426fcc48d1e2d | 245 | Pfam | PF13374 | Tetratricopeptide repeat | 201 | 241 | 2.5E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/73003|m.18481 | UnnamedSample_HQ_transcript/73003 | Coverage 0.060 too low. | 1ba7946721192633c6cbc25e0b971016 | 566 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 376 | 426 | 1.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/73003|m.18481 | UnnamedSample_HQ_transcript/73003 | Coverage 0.060 too low. | 1ba7946721192633c6cbc25e0b971016 | 566 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 310 | 365 | 9.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/73003|m.18481 | UnnamedSample_HQ_transcript/73003 | Coverage 0.060 too low. | 1ba7946721192633c6cbc25e0b971016 | 566 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 175 | 225 | 4.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/73003|m.18481 | UnnamedSample_HQ_transcript/73003 | Coverage 0.060 too low. | 1ba7946721192633c6cbc25e0b971016 | 566 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 262 | 316 | 2.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6282|m.2632 | UnnamedSample_HQ_transcript/6282 | Coverage 0.177 too low. | 7ac3ab87caf6cd38a222757153eecde7 | 345 | Pfam | PF12407 | Homeobox protein | 275 | 298 | 4.3E-9 | T | 22-09-2020 | IPR022132 | Homeobox protein |
| UnnamedSample_HQ_transcript/6282|m.2632 | UnnamedSample_HQ_transcript/6282 | Coverage 0.177 too low. | 7ac3ab87caf6cd38a222757153eecde7 | 345 | Pfam | PF00046 | Homeodomain | 218 | 274 | 5.9E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/14316|m.5200 | UnnamedSample_HQ_transcript/14316 | Coverage 0.330 too low. | 7ac3ab87caf6cd38a222757153eecde7 | 345 | Pfam | PF12407 | Homeobox protein | 275 | 298 | 4.3E-9 | T | 22-09-2020 | IPR022132 | Homeobox protein |
| UnnamedSample_HQ_transcript/14316|m.5200 | UnnamedSample_HQ_transcript/14316 | Coverage 0.330 too low. | 7ac3ab87caf6cd38a222757153eecde7 | 345 | Pfam | PF00046 | Homeodomain | 218 | 274 | 5.9E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/4890|m.2146 | UnnamedSample_HQ_transcript/4890 | Coverage 0.252 too low. | 7ac3ab87caf6cd38a222757153eecde7 | 345 | Pfam | PF12407 | Homeobox protein | 275 | 298 | 4.3E-9 | T | 22-09-2020 | IPR022132 | Homeobox protein |
| UnnamedSample_HQ_transcript/4890|m.2146 | UnnamedSample_HQ_transcript/4890 | Coverage 0.252 too low. | 7ac3ab87caf6cd38a222757153eecde7 | 345 | Pfam | PF00046 | Homeodomain | 218 | 274 | 5.9E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 882 | 933 | 1.0E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 688 | 708 | 0.014 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 772 | 817 | 5.5E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 337 | 384 | 2.3E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 984 | 1027 | 7.6E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 723 | 769 | 4.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 276 | 324 | 9.7E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 936 | 981 | 1.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 393 | 437 | 3.1E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 827 | 875 | 7.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 440 | 490 | 7.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 41 | 273 | 1.3E-68 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/3148|m.1503 | UnnamedSample_HQ_transcript/3148 | Identity 0.908 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00052 | Laminin B (Domain IV) | 556 | 687 | 1.4E-26 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 882 | 933 | 1.0E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 688 | 708 | 0.014 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 772 | 817 | 5.5E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 337 | 384 | 2.3E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 984 | 1027 | 7.6E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 723 | 769 | 4.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 276 | 324 | 9.7E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 936 | 981 | 1.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 393 | 437 | 3.1E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 827 | 875 | 7.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00053 | Laminin EGF domain | 440 | 490 | 7.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 41 | 273 | 1.3E-68 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/2698|m.1320 | UnnamedSample_HQ_transcript/2698 | Identity 0.910 too low. | 9a4b5a38954105fc036f09f819d7c5af | 1620 | Pfam | PF00052 | Laminin B (Domain IV) | 556 | 687 | 1.4E-26 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF00041 | Fibronectin type III domain | 274 | 376 | 1.9E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF00041 | Fibronectin type III domain | 510 | 589 | 4.9E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF00041 | Fibronectin type III domain | 1217 | 1295 | 8.5E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF00041 | Fibronectin type III domain | 719 | 806 | 8.8E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF00041 | Fibronectin type III domain | 828 | 907 | 2.4E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF01682 | DB module | 409 | 500 | 5.7E-14 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF01682 | DB module | 618 | 709 | 7.2E-16 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF01682 | DB module | 172 | 265 | 1.6E-16 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF01682 | DB module | 1121 | 1207 | 9.9E-15 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF07686 | Immunoglobulin V-set domain | 35 | 129 | 3.6E-8 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/3921|m.1782 | UnnamedSample_HQ_transcript/3921 | Coverage 0.093 too low. | 155956e89b84d848098e18b84b4e3446 | 1440 | Pfam | PF07679 | Immunoglobulin I-set domain | 1021 | 1109 | 1.6E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7811|m.3125 | UnnamedSample_HQ_transcript/7811 | Coverage 0.974 too low. | 80ec8a7290cbcfba03db99b8af96a6d7 | 1285 | Pfam | PF10350 | Putative death-receptor fusion protein (DUF2428) | 407 | 650 | 1.4E-57 | T | 22-09-2020 | IPR019442 | Domain of unknown function DUF2428, death-receptor-like |
| UnnamedSample_HQ_transcript/74306|m.18706 | UnnamedSample_HQ_transcript/74306 | Coverage 0.719 too low. | b87a5d9dfa8917b6fdf23a2c91a6586e | 420 | Pfam | PF00246 | Zinc carboxypeptidase | 94 | 380 | 1.8E-65 | T | 22-09-2020 | IPR000834 | Peptidase M14, carboxypeptidase A |
| UnnamedSample_HQ_transcript/69035|m.17768 | UnnamedSample_HQ_transcript/69035 | Coverage 0.742 too low. | b87a5d9dfa8917b6fdf23a2c91a6586e | 420 | Pfam | PF00246 | Zinc carboxypeptidase | 94 | 380 | 1.8E-65 | T | 22-09-2020 | IPR000834 | Peptidase M14, carboxypeptidase A |
| UnnamedSample_HQ_transcript/3329|m.1574 | UnnamedSample_HQ_transcript/3329 | Coverage 0.129 too low. | 6dfe612ad63029e89b55e965b4cf7aa3 | 1184 | Pfam | PF00621 | RhoGEF domain | 340 | 520 | 1.0E-35 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/3329|m.1574 | UnnamedSample_HQ_transcript/3329 | Coverage 0.129 too low. | 6dfe612ad63029e89b55e965b4cf7aa3 | 1184 | Pfam | PF19057 | PH domain | 545 | 678 | 3.3E-38 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3329|m.1574 | UnnamedSample_HQ_transcript/3329 | Coverage 0.129 too low. | 6dfe612ad63029e89b55e965b4cf7aa3 | 1184 | Pfam | PF19056 | WD40 repeated domain | 844 | 1072 | 1.4E-60 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4338|m.1930 | UnnamedSample_HQ_transcript/4338 | Coverage 0.057 too low. | ac27346f42d6f30a08785db4b40c36d3 | 429 | Pfam | PF07647 | SAM domain (Sterile alpha motif) | 374 | 413 | 1.3E-6 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/7302|m.2954 | UnnamedSample_HQ_transcript/7302 | Coverage 0.975 too low. | a75e5879ff84ac8ac60b7549552fdf77 | 384 | Pfam | PF02984 | Cyclin, C-terminal domain | 17 | 87 | 7.0E-5 | T | 22-09-2020 | IPR004367 | Cyclin, C-terminal domain |
| UnnamedSample_HQ_transcript/23729|m.7872 | UnnamedSample_HQ_transcript/23729 | Coverage 0.556 too low. | df8564d7f49e577591356fc70b89c561 | 768 | Pfam | PF00005 | ABC transporter | 550 | 690 | 1.2E-16 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/23729|m.7872 | UnnamedSample_HQ_transcript/23729 | Coverage 0.556 too low. | df8564d7f49e577591356fc70b89c561 | 768 | Pfam | PF06472 | ABC transporter transmembrane region 2 | 142 | 416 | 1.3E-87 | T | 22-09-2020 | IPR011527 | ABC transporter type 1, transmembrane domain |
| UnnamedSample_HQ_transcript/19068|m.6604 | UnnamedSample_HQ_transcript/19068 | Coverage 0.527 too low. | df8564d7f49e577591356fc70b89c561 | 768 | Pfam | PF00005 | ABC transporter | 550 | 690 | 1.2E-16 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/19068|m.6604 | UnnamedSample_HQ_transcript/19068 | Coverage 0.527 too low. | df8564d7f49e577591356fc70b89c561 | 768 | Pfam | PF06472 | ABC transporter transmembrane region 2 | 142 | 416 | 1.3E-87 | T | 22-09-2020 | IPR011527 | ABC transporter type 1, transmembrane domain |
| UnnamedSample_HQ_transcript/99298|m.22539 | UnnamedSample_HQ_transcript/99298 | Coverage 0.989 too low. | c6197cc589598e3c794d8111284813b2 | 355 | Pfam | PF05285 | SDA1 | 19 | 354 | 5.8E-88 | T | 22-09-2020 | IPR007949 | SDA1 domain |
| UnnamedSample_HQ_transcript/26921|m.8698 | UnnamedSample_HQ_transcript/26921 | Coverage 0.637 too low. | 2fb714137118532ed0868a1de7c5821c | 647 | Pfam | PF00520 | Ion transport protein | 170 | 499 | 3.2E-19 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/32116|m.9981 | UnnamedSample_HQ_transcript/32116 | Coverage 0.069 too low. | 97df0e8b71825436eb7069acb7966dcd | 548 | Pfam | PF02188 | GoLoco motif | 55 | 75 | 2.6E-8 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/32116|m.9981 | UnnamedSample_HQ_transcript/32116 | Coverage 0.069 too low. | 97df0e8b71825436eb7069acb7966dcd | 548 | Pfam | PF02145 | Rap/ran-GAP | 300 | 480 | 3.4E-70 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/107067|m.23473 | UnnamedSample_HQ_transcript/107067 | Coverage 0.782 too low. | fff0dfbccc2211d8289924f16e56feaa | 266 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 50 | 183 | 6.2E-44 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/107067|m.23473 | UnnamedSample_HQ_transcript/107067 | Coverage 0.782 too low. | fff0dfbccc2211d8289924f16e56feaa | 266 | Pfam | PF17862 | AAA+ lid domain | 206 | 249 | 5.6E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/97219|m.22267 | UnnamedSample_HQ_transcript/97219 | Coverage 0.819 too low. | fff0dfbccc2211d8289924f16e56feaa | 266 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 50 | 183 | 6.2E-44 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/97219|m.22267 | UnnamedSample_HQ_transcript/97219 | Coverage 0.819 too low. | fff0dfbccc2211d8289924f16e56feaa | 266 | Pfam | PF17862 | AAA+ lid domain | 206 | 249 | 5.6E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/84907|m.20483 | UnnamedSample_HQ_transcript/84907 | Coverage 0.269 too low. | 585d05d8ef2b3b8b6d65667bfaced3c2 | 148 | Pfam | PF13639 | Ring finger domain | 32 | 74 | 4.6E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/83133|m.20215 | UnnamedSample_HQ_transcript/83133 | Coverage 0.242 too low. | 585d05d8ef2b3b8b6d65667bfaced3c2 | 148 | Pfam | PF13639 | Ring finger domain | 32 | 74 | 4.6E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/43133|m.12518 | UnnamedSample_HQ_transcript/43133 | Coverage 0.624 too low. | 5c86f81fd7b1fb940e0f352ba5c53a0c | 284 | Pfam | PF00307 | Calponin homology (CH) domain | 133 | 239 | 2.4E-22 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/7373|m.2976 | UnnamedSample_HQ_transcript/7373 | Identity 0.747 too low. | 2a83f0aff0463cf484188709a6a02054 | 1059 | Pfam | PF03607 | Doublecortin | 173 | 226 | 7.0E-12 | T | 22-09-2020 | IPR003533 | Doublecortin domain |
| UnnamedSample_HQ_transcript/7373|m.2976 | UnnamedSample_HQ_transcript/7373 | Identity 0.747 too low. | 2a83f0aff0463cf484188709a6a02054 | 1059 | Pfam | PF00400 | WD domain, G-beta repeat | 782 | 813 | 0.004 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/7373|m.2976 | UnnamedSample_HQ_transcript/7373 | Identity 0.747 too low. | 2a83f0aff0463cf484188709a6a02054 | 1059 | Pfam | PF00400 | WD domain, G-beta repeat | 501 | 544 | 0.005 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/7373|m.2976 | UnnamedSample_HQ_transcript/7373 | Identity 0.747 too low. | 2a83f0aff0463cf484188709a6a02054 | 1059 | Pfam | PF03451 | HELP motif | 429 | 496 | 2.0E-23 | T | 22-09-2020 | IPR005108 | HELP |
| UnnamedSample_HQ_transcript/8166|m.3248 | UnnamedSample_HQ_transcript/8166 | Coverage 0.138 too low. | b5d41e7d5701693c51db40bbc017af0d | 1228 | Pfam | PF09469 | Cordon-bleu ubiquitin-like domain | 105 | 189 | 9.6E-6 | T | 22-09-2020 | IPR019025 | Cordon-bleu, ubiquitin-like domain |
| UnnamedSample_HQ_transcript/63649|m.16767 | UnnamedSample_HQ_transcript/63649 | Coverage 0.878 too low. | bf7519b1cfd822e0479581d8e7c5fe60 | 455 | Pfam | PF00617 | RasGEF domain | 2 | 144 | 1.5E-42 | T | 22-09-2020 | IPR001895 | Ras guanine-nucleotide exchange factors catalytic domain |
| UnnamedSample_HQ_transcript/63649|m.16767 | UnnamedSample_HQ_transcript/63649 | Coverage 0.878 too low. | bf7519b1cfd822e0479581d8e7c5fe60 | 455 | Pfam | PF00169 | PH domain | 334 | 439 | 3.8E-6 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/86146|m.20676 | UnnamedSample_HQ_transcript/86146 | Identity 0.947 too low. | c44e26dc6c2de760d6c43f1935c1e1e5 | 163 | Pfam | PF00125 | Core histone H2A/H2B/H3/H4 | 45 | 161 | 3.7E-34 | T | 22-09-2020 | IPR007125 | Histone H2A/H2B/H3 |
| UnnamedSample_HQ_transcript/82009|m.20030 | UnnamedSample_HQ_transcript/82009 | Coverage 0.366 too low. | b34516df4bf353f4451afc8b35ec775f | 204 | Pfam | PF00042 | Globin | 54 | 158 | 1.7E-19 | T | 22-09-2020 | IPR000971 | Globin |
| UnnamedSample_HQ_transcript/15797|m.5641 | UnnamedSample_HQ_transcript/15797 | Identity 0.885 too low. | f37594c877ea553d0f5e7de82835a958 | 1018 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 455 | 524 | 4.9E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/15797|m.5641 | UnnamedSample_HQ_transcript/15797 | Identity 0.885 too low. | f37594c877ea553d0f5e7de82835a958 | 1018 | Pfam | PF02037 | SAP domain | 12 | 44 | 2.2E-9 | T | 22-09-2020 | IPR003034 | SAP domain |
| UnnamedSample_HQ_transcript/829|m.555 | UnnamedSample_HQ_transcript/829 | Unmapped. | 3b769e7b8c9effdcbfdf2dcd557c8b40 | 770 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 734 | 9.6E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/68071|m.17592 | UnnamedSample_HQ_transcript/68071 | Coverage 0.726 too low. | 4e993885b3fccf7ec4898917ec4c28c5 | 306 | Pfam | PF10545 | Alcohol dehydrogenase transcription factor Myb/SANT-like | 14 | 97 | 4.7E-20 | T | 22-09-2020 | IPR006578 | MADF domain |
| UnnamedSample_HQ_transcript/64774|m.16996 | UnnamedSample_HQ_transcript/64774 | Coverage 0.422 too low. | 675de5c4b0fe27ecefb41c6553819fba | 418 | Pfam | PF03022 | Major royal jelly protein | 123 | 400 | 1.5E-76 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/83783|m.20312 | UnnamedSample_HQ_transcript/83783 | Coverage 0.267 too low. | 675de5c4b0fe27ecefb41c6553819fba | 418 | Pfam | PF03022 | Major royal jelly protein | 123 | 400 | 1.5E-76 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/72623|m.18406 | UnnamedSample_HQ_transcript/72623 | Coverage 0.360 too low. | 675de5c4b0fe27ecefb41c6553819fba | 418 | Pfam | PF03022 | Major royal jelly protein | 123 | 400 | 1.5E-76 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/49154|m.13844 | UnnamedSample_HQ_transcript/49154 | Unmapped. | 3b059d6698971559cd9c885ca725bb2e | 407 | Pfam | PF04564 | U-box domain | 330 | 401 | 1.2E-30 | T | 22-09-2020 | IPR003613 | U box domain |
| UnnamedSample_HQ_transcript/49154|m.13844 | UnnamedSample_HQ_transcript/49154 | Unmapped. | 3b059d6698971559cd9c885ca725bb2e | 407 | Pfam | PF10408 | Ubiquitin elongating factor core | 1 | 313 | 2.3E-98 | T | 22-09-2020 | IPR019474 | Ubiquitin conjugation factor E4, core |
| UnnamedSample_HQ_transcript/54025|m.14837 | UnnamedSample_HQ_transcript/54025 | Unmapped. | 3b059d6698971559cd9c885ca725bb2e | 407 | Pfam | PF04564 | U-box domain | 330 | 401 | 1.2E-30 | T | 22-09-2020 | IPR003613 | U box domain |
| UnnamedSample_HQ_transcript/54025|m.14837 | UnnamedSample_HQ_transcript/54025 | Unmapped. | 3b059d6698971559cd9c885ca725bb2e | 407 | Pfam | PF10408 | Ubiquitin elongating factor core | 1 | 313 | 2.3E-98 | T | 22-09-2020 | IPR019474 | Ubiquitin conjugation factor E4, core |
| UnnamedSample_HQ_transcript/43261|m.12547 | UnnamedSample_HQ_transcript/43261 | Coverage 0.050 too low. | 3b059d6698971559cd9c885ca725bb2e | 407 | Pfam | PF04564 | U-box domain | 330 | 401 | 1.2E-30 | T | 22-09-2020 | IPR003613 | U box domain |
| UnnamedSample_HQ_transcript/43261|m.12547 | UnnamedSample_HQ_transcript/43261 | Coverage 0.050 too low. | 3b059d6698971559cd9c885ca725bb2e | 407 | Pfam | PF10408 | Ubiquitin elongating factor core | 1 | 313 | 2.3E-98 | T | 22-09-2020 | IPR019474 | Ubiquitin conjugation factor E4, core |
| UnnamedSample_HQ_transcript/37544|m.11286 | UnnamedSample_HQ_transcript/37544 | Coverage 0.355 too low. | f191cedcfb5ab4efe30cf8b8a6103a69 | 557 | Pfam | PF00435 | Spectrin repeat | 418 | 507 | 3.9E-6 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/59535|m.15961 | UnnamedSample_HQ_transcript/59535 | Coverage 0.459 too low. | ee7eca6e4b4e66df766379767fbc68ba | 257 | Pfam | PF07993 | Male sterility protein | 25 | 242 | 5.5E-56 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/94847|m.21933 | UnnamedSample_HQ_transcript/94847 | Coverage 0.984 too low. | 98a333a7d5dd86c11c5f1ef612efd8b1 | 280 | Pfam | PF02784 | Pyridoxal-dependent decarboxylase, pyridoxal binding domain | 6 | 140 | 3.7E-25 | T | 22-09-2020 | IPR022644 | Orn/DAP/Arg decarboxylase 2, N-terminal |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
